Jing Xu, Jilong Ren, Kai Xu, Minghui Fang, Meina Ka, Fei Xu, Xin Wang, Jing Wang, Zhiqiang Han, Guihai Feng, Ying Zhang, Tang Hai, Wei Li, Zheng Hu
{"title":"Elimination of GGTA1, CMAH, β4GalNT2 and CIITA genes in pigs compromises human versus pig xenogeneic immune reactions","authors":"Jing Xu, Jilong Ren, Kai Xu, Minghui Fang, Meina Ka, Fei Xu, Xin Wang, Jing Wang, Zhiqiang Han, Guihai Feng, Ying Zhang, Tang Hai, Wei Li, Zheng Hu","doi":"10.1002/ame2.12461","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Pig organ xenotransplantation is a potential solution for the severe organ shortage in clinic, while immunogenic genes need to be eliminated to improve the immune compatibility between humans and pigs. Current knockout strategies are mainly aimed at the genes causing hyperacute immune rejection (HAR) that occurs in the first few hours while adaptive immune reactions orchestrated by CD4 T cell thereafter also cause graft failure, in which process the MHC II molecule plays critical roles.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Thus, we generate a 4-gene (<i>GGTA1, CMAH, β4GalNT2,</i> and <i>CIITA</i>) knockout pig by CRISPR/Cas9 and somatic cell nuclear transfer to compromise HAR and CD4 T cell reactions simultaneously.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>We successfully obtained 4KO piglets with deficiency in all alleles of genes, and at cellular and tissue levels. Additionally, the safety of our animals after gene editing was verified by using whole-genome sequencing and karyotyping. Piglets have survived for more than one year in the barrier, and also survived for more than 3 months in the conventional environment, suggesting that the piglets without MHC II can be raised in the barrier and then gradually mated in the conventional environment.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>4KO piglets have lower immunogenicity, are safe in genomic level, and are easier to breed than the model with both MHC I and II deletion.</p>\n </section>\n </div>","PeriodicalId":93869,"journal":{"name":"Animal models and experimental medicine","volume":"7 4","pages":"584-590"},"PeriodicalIF":0.0000,"publicationDate":"2024-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ame2.12461","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Animal models and experimental medicine","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ame2.12461","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Health Professions","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Pig organ xenotransplantation is a potential solution for the severe organ shortage in clinic, while immunogenic genes need to be eliminated to improve the immune compatibility between humans and pigs. Current knockout strategies are mainly aimed at the genes causing hyperacute immune rejection (HAR) that occurs in the first few hours while adaptive immune reactions orchestrated by CD4 T cell thereafter also cause graft failure, in which process the MHC II molecule plays critical roles.
Methods
Thus, we generate a 4-gene (GGTA1, CMAH, β4GalNT2, and CIITA) knockout pig by CRISPR/Cas9 and somatic cell nuclear transfer to compromise HAR and CD4 T cell reactions simultaneously.
Results
We successfully obtained 4KO piglets with deficiency in all alleles of genes, and at cellular and tissue levels. Additionally, the safety of our animals after gene editing was verified by using whole-genome sequencing and karyotyping. Piglets have survived for more than one year in the barrier, and also survived for more than 3 months in the conventional environment, suggesting that the piglets without MHC II can be raised in the barrier and then gradually mated in the conventional environment.
Conclusions
4KO piglets have lower immunogenicity, are safe in genomic level, and are easier to breed than the model with both MHC I and II deletion.
背景:猪器官异种移植是解决临床上器官严重短缺问题的一种潜在方法,但需要消除免疫原性基因以改善人与猪之间的免疫相容性。目前的基因敲除策略主要针对导致超急性免疫排斥反应(HAR)的基因,这种排斥反应发生在最初几小时,而此后由 CD4 T 细胞协调的适应性免疫反应也会导致移植失败,在这一过程中,MHC II 分子起着关键作用:因此,我们通过 CRISPR/Cas9 和体细胞核移植技术产生了 4 个基因(GGTA1、CMAH、β4GalNT2 和 CIITA)敲除猪,以同时影响 HAR 和 CD4 T 细胞反应:结果:我们成功地获得了在细胞和组织水平上所有等位基因都缺乏的 4KO 仔猪。此外,我们还通过全基因组测序和核型分析验证了基因编辑后动物的安全性。仔猪在屏障中存活了一年多,在常规环境中也存活了 3 个多月,这表明没有 MHC II 的仔猪可以在屏障中饲养,然后逐渐在常规环境中交配:结论:与同时缺失 MHC I 和 II 的模型相比,4KO 仔猪的免疫原性更低、基因组水平更安全、更容易繁殖。